Enesi Pharma Limited

Activities: Pharmaceutical

Trending Articles

  1. NICE approves KEYTRUDA as first perioperative immunotherapy for locally advanced head and neck cancer MSD's KEYTRUDA (pembrolizumab) has received NICE approval as a neoadjuvant and adjuvant therapy for resectable LA HNSCC—the first immunotherapy recommended in this...
  2. Destination Russia for new NYK Logistics warehouse Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.
  3. Pfizer agrees sale of consumer healthcare business to J&J Pfizer Inc has reached an agreement to sell its consumer healthcare business to Johnson & Johnson (J&J) for US$16.6bn (euro13.2bn) in cash.
  4. Pfizer's HYMPAVZI receives positive CHMP opinion for haemophilia A and B patients with inhibitors The EMA's Committee for Medicinal Products for Human Use has recommended expanding the approved indication for Pfizer's HYMPAVZI to include adolescents and adults with...
  5. AstraZeneca's tozorakimab meets primary endpoint in both Phase III COPD trials AstraZeneca has reported positive results from the OBERON and TITANIA Phase III trials, with tozorakimab significantly reducing moderate-to-severe COPD exacerbations compared...

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Enesi Pharma and NIAID to test novel flu vaccines

The vaccines will be developed using Enesi Pharma’s ImplaVax technology
Ingredients

Enesi Pharma hits milestone in thermostable solid-dose live vaccines development

Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella
Drug Delivery

Enesi and Oxford Vaccine Group partner to immunise against plague

Collaboration aims to create an easy-to-use solid dose plague vaccine for use in areas of outbreak and as a defence against bioterrorism
Media

Needle-free vaccine collaboration for emergent threat pathogens

Enesi Pharma has entered a research and development collaboration with Public Health England
Pharmaceutical

Enesi welcomes global vaccine expert to Scientific Advisory Board
Subscribe now